FAPI PET/CT显像中的非肿瘤性生理性与病理性摄取
成纤维细胞激活蛋白抑制剂(FAPI)PET/CT在多种肿瘤中较18F-FDG PET/CT具有更高的靶本比,随着研究增多,非肿瘤性摄取报道日益增加。本文按器官系统综述FAPI-02、FAPI-04和FAPI-46的生理性摄取模式及文献报道的非肿瘤性摄取主要原因,并展示加州大学洛杉矶分校(UCLA)机构数据库中的示例。了解这些摄取模式对准确解读FAPI PET/CT和合理处理偶然发现至关重要。
要点
- FAPI PET/CT可显示良性肿瘤、纤维化、肉芽肿、瘢痕/创伤、退行性及炎症性病变的非肿瘤性摄取。
- 按器官系统认识生理性FAPI摄取模式是避免误判的前提。
- 文献报道的非肿瘤性摄取主要基于FAPI-02、FAPI-04和FAPI-46。
核心结论
- 了解生理性和非肿瘤性FAPI摄取原因对于准确解读FAPI PET/CT及合理处理肿瘤分期患者的偶然发现不可或缺。
研究设计与样本
- 综述,按器官系统描述生理性FAPI摄取模式及文献报道的非肿瘤性摄取原因,并展示UCLA机构数据库示例;涉及FAPI-02、FAPI-04和FAPI-46。
关键影像表现/征象
- 非肿瘤性FAPI摄取可见于良性肿瘤、纤维化、肉芽肿、瘢痕/创伤、退行性疾病和炎症性疾病。
- 按器官系统(脑、口腔黏膜、唾液腺、甲状腺、肺、心肌、乳腺、食管、胃、肠、肝、胆囊、胰腺、脾、肾、子宫、骨髓、关节、肌肉、血管、淋巴结)描述了生理性FAPI摄取模式。
临床应用与阅片要点
- 解读FAPI PET/CT时需结合生理性摄取模式识别非肿瘤性摄取,以帮助合理处理肿瘤分期患者的偶然发现。
- 文献报道的非肿瘤性摄取原因主要来自FAPI-02、FAPI-04和FAPI-46。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Fibroblast-activation protein (FAP) is a serine protease classified in the dipeptidyl peptidase 4 (DPP4) family. FAP is predominantly expressed in activated fibroblasts such as the cancer-associated fibroblasts (CAFs). FAP expression in CAFs is associated with tumor progression and poor prognosis in solid cancers. Recently, radiolabeled FAP inhibitors (FAPI) has been developed, which enables positron emission tomography (PET) imaging of FAP. FAPI PET/CT can provide a higher tumor-to-background ratio (TBR) than 18F-fludeoxyglucose PET/CT in various cancers, and thus has attracted substantial attention. As studies on FAPI PET grow in number and size, incidental findings related to non-oncologic conditions have been increasingly reported. FAPI PET uptake has been reported in various conditions such as benign tumors, fibrotic, granulomatosis, scarring/wound, degenerative diseases, and inflammatory diseases.The knowledge of physiological and non-oncologic causes of FAPI uptake is indispensable for accurate FAPI PET/CT interpretation and can help appropriate management of incidental findings on FAPI PET/CT in patients referred for cancer staging indications. In this review article, we describe for each organ system (Brain, Oral mucosa, Salivary Glands, Thyroid, Lung, Myocardium, Breast, Esophagus, Stomach, Intestine, Liver, Gallbladder, Pancreas, Spleen, Kidney, , Uterus, Bone marrow, Joints, Muscle, Vessels, Lymph nodes), the patterns of physiological FAPI uptake and the main causes of non-oncological uptake reported from the literature with FAPI-02, FAPI-04 and FAPI-46. We also illustrate some examples from our institutional database at UCLA.
引用
- Hotta, Rieger, Jafarvand, et al. Non-oncologic incidental uptake on FAPI PET/CT imaging. Br J Radiol. 2022. PMID: 35776566. doi:10.1259/bjr.20220463
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。